Influenza Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC) to provide registered users with reagents, tools and information for studying and detection of Influenza Virus. The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved diagnostic tests, vaccines, and detection methods. Public health labs also use the reagents across the globe for the surveillance of newly emerging strains of Influenza, such as Influenza (H1N1) and (H5N1). By centralizing these functions within the IRR, access to and use of these materials in the scientific and public health community is monitored and quality control of the reagents is assured.
The Influenza Reagent Resource is managed under contract by American Type Culture Collection (ATCC). A one-year contract with nine option years to manage IRR was awarded to ATCC in September 2008.
Principal Investigator: Dr. Ted Mullins
Funding Agency: Centers for Disease Control and Prevention (CDC)